Fed Pullback Pledge...
Health Care: Drugs
Threshold Pharmaceuticals Inc. (THLD: NASDAQ)
$5.46 -0.04 | -0.73%
06/19/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 5.87M | 62.00K | 0.00 | 0.00 |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 5.87M | 62.00K | 0.00 | 0.00 |
| Selling, General, and Administrative Expenses | 7.08M | 5.71M | 4.97M | 5.48M |
| Research & Development | 18.79M | 24.39M | 18.94M | 15.84M |
| Operating Income before D & A (EBITDA) | -20.00M | -30.04M | -23.91M | -21.32M |
| Depreciation & Amortization | 1.01M | 525.00K | 509.00K | 597.00K |
| Interest Income | 80.00K | 25.00K | 60.00K | 97.00K |
| Other Income - Net | -51.22M | 4.36M | 5.17M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -72.14M | -26.18M | -19.19M | -21.82M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 2.42M |
| Pre-Tax Income | -72.14M | -26.18M | -19.19M | -24.24M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -71.14M | -25.65M | -18.68M | -23.65M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -71.14M | -25.65M | -18.68M | -23.65M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -71.14M | -25.65M | -18.68M | -23.65M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-71.14M | -25.65M | -18.68M | -23.65M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -71.14M | -25.65M | -18.68M | -23.65M |
| Basic EPS from Continuing Ops. | -1.31 | -0.56 | -0.56 | -1.21 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.31 | -0.56 | -0.56 | -1.21 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.31 | -0.56 | -0.56 | -1.21 |
| Basic Normalized Net Income/Share | -1.31 | -0.56 | -0.56 | -1.21 |
| EPS fr Continuing Ops. | -1.31 | -0.56 | -0.56 | -1.21 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.31 | -0.56 | -0.56 | -1.21 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.31 | -0.56 | -0.56 | -1.21 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.31 | -0.56 | -0.56 | -1.21 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with THLD
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBasement money
- UserStock Interests, Ideas & Re...
- UserMy Watch
- UserGopher Gold
- UserBlue Horseshoe loves Andeco...
- UserJARBAS ROCHA
Latest THLD Headlines from TheStreet
- Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 16% 05.24.13 | 01:05 pm
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- 5 Stocks Poised for Breakouts 03.01.13 | 02:03 pm
- 4 Biotech Stocks Under $10 Moving Higher 02.20.13 | 09:02 pm
- 3 Biotech Stocks Under $10 Moving Higher 02.12.13 | 02:02 pm
- Stocks Continue to Climb as Companies Exceed Expectations 01.25.13 | 04:01 pm
- Biotech Stock Mailbag: Keryx, Sangamo, Threshold and Amarin 01.25.13 | 07:01 am
- Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial 01.22.13 | 06:01 pm
- 4 Biotech Stocks Spiking on Unusual Volume 01.08.13 | 02:01 pm
- 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook 11.27.12 | 06:11 am
Press Releases for THLD
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Threshold Pharmaceuticals Inc. - PR Newswire 04.03.13 | 05:04 pm
- Threshold Pharmaceuticals Reports Second Quarter 2011 Financial And Operational Results - Business Wire 08.04.11 | 04:08 pm
- Threshold Pharmaceuticals Announces Initiation Of Clinical Trial Evaluating TH-302 In Combination With Bevacizumab At University Of Texas At San Antonio - Business Wire 07.25.11 | 09:07 am
- Threshold Pharmaceuticals Announces National Comprehensive Cancer Network (NCCN) Grant For Phase 1 Trial Of TH-302 In Combination With Pazopanib - Business Wire 07.06.11 | 08:07 am
- Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib - Business Wire 06.29.11 | 06:06 am
- Threshold Pharmaceuticals To Present At OneMedForum Conference - Business Wire 06.22.11 | 06:06 am
- Threshold Pharmaceuticals Announces Completion Of Patient Recruitment For Phase 2 TH-302 Pancreatic Cancer Study - Business Wire 06.21.11 | 04:06 pm
Partner Headlines for THLD
- A Journey To Add Biotech To The Portfolio - Seeking Alpha 05.18.13 | 02:05 am
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- Threshold Pharmaceuticals - A Derivative Trade On Ziopharm's Upcoming Data - Seeking Alpha 03.22.13 | 09:03 am
- UPDATE: Maxim Group Initiates Threshold Pharmaceuticals at Buy on Doxorubicin Potential - Benzinga 09.20.12 | 01:09 pm
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 09.18.12 | 09:09 am
- Morning Market Losers - Benzinga 09.17.12 | 09:09 am
- Buy Zalicus For A 120% Upside - Seeking Alpha 09.05.12 | 09:09 am
- Worthington INITIATED Buy and 3 Analyst-Initiated Stocks To Note - Wall St. Cheat Sheet 07.10.12 | 04:07 am
- Best Performing Stocks At 2012's Midpoint - Seeking Alpha 06.29.12 | 07:06 pm
- Healthcare Biz Recap: Express Scripts New Driver, Elan Pops - Wall St. Cheat Sheet 05.27.12 | 12:05 pm
